ZA8841B - - Google Patents

Info

Publication number
ZA8841B
ZA8841B ZA8841A ZA8841A ZA8841B ZA 8841 B ZA8841 B ZA 8841B ZA 8841 A ZA8841 A ZA 8841A ZA 8841 A ZA8841 A ZA 8841A ZA 8841 B ZA8841 B ZA 8841B
Authority
ZA
South Africa
Application number
ZA8841A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of ZA8841B publication Critical patent/ZA8841B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA8841A 1987-01-05 1988-01-05 ZA8841B (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL81166A IL81166A (en) 1987-01-05 1987-01-05 Pharmaceutically active combination comprising an ionic vanadium compound and thiosulfate or sulfite compound and optionally selenium

Publications (1)

Publication Number Publication Date
ZA8841B true ZA8841B (ja) 1988-06-24

Family

ID=11057417

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA8841A ZA8841B (ja) 1987-01-05 1988-01-05

Country Status (6)

Country Link
US (1) US5045316A (ja)
EP (1) EP0274404A1 (ja)
JP (1) JPS63239227A (ja)
AU (1) AU594851B2 (ja)
IL (1) IL81166A (ja)
ZA (1) ZA8841B (ja)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990012563A1 (en) * 1989-04-24 1990-11-01 Board Of Regents, The University Of Texas System Compositions and processes for improving the cosmetic appearance, growths or healing characteristics of tissue
DE4336642C2 (de) * 1993-10-22 1995-08-10 Deutsches Rheuma Forschungszen Verwendung von Vanadiumverbindungen mit antiviraler Wirkung
US5639482A (en) * 1993-11-10 1997-06-17 Crary; Ely J. Composition for control and prevention of diabetic retinopathy
US5871779A (en) * 1994-01-18 1999-02-16 Mount Sinai Hospital Corporation Treatment of arthropathies with vanadate compounds or analogues thereof
US5843481A (en) * 1994-01-18 1998-12-01 Mount Sinai Hospital Corporation Treatment of proliferative disorders, metastasaes, and drug resistant tumors with vanadate compounds and derivatives or analogues thereof
US5962030A (en) 1997-03-07 1999-10-05 Akesis Pharmaceuticals, Inc. Dietary supplement and method of treatment for diabetic control
US6376549B1 (en) * 1998-09-17 2002-04-23 Akesis Pharmaceuticals, Inc. Metforimin-containing compositions for the treatment of diabetes
EP1113804A2 (en) * 1998-09-17 2001-07-11 Akesis Pharmaceuticals, Inc. Combinations of chromium or vanadium with antidiabetics for glucose metabolism disorders
WO2000044774A2 (en) * 1999-01-27 2000-08-03 The University Of South Florida Inhibition of stat3 signal transduction for human cancer therapy
US20040052762A1 (en) * 2001-09-10 2004-03-18 Hua Yu Stat3 agonists and antagonists and therapeutic uses thereof
DE10135494A1 (de) * 2001-07-20 2003-11-06 Jobst Krauskopf Verwendung eines Lactatsalzes zur Behandlung und Prophylaxe der Athereosklerose
US7638122B2 (en) * 2003-03-07 2009-12-29 University Of South Florida Stat3 antagonists and their use as vaccines against cancer
DE102004025988A1 (de) * 2004-05-21 2005-12-08 Petersen, Jan, Dr. Verwendung von Vanadylverbindungen zur Behandlung von Tumorerkrankungen
WO2014116097A2 (es) 2013-01-28 2014-07-31 Nuevas Alternativas Naturales Thermafat, S.A.P.I. De C.V. Composiciones para tratamiento sistémico de condiciones patológicas resultantes de estrés oxidativo y/o desequilibrio redox
US11289700B2 (en) 2016-06-28 2022-03-29 The Research Foundation For The State University Of New York KVOPO4 cathode for sodium ion batteries

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2135111A (en) * 1936-04-27 1938-11-01 Harry J Prebluda Vanadyl lactate and process of making it
US4657764A (en) * 1983-05-26 1987-04-14 T & R Chemicals, Inc. Treatment of arthritis and arthritic conditions with sulfites and bisulfites
US4462988A (en) * 1983-05-26 1984-07-31 T&R Chemicals, Inc. Treatment of arthritis with bisulfite
DE3419686A1 (de) * 1983-05-26 1984-11-29 T and R Chemicals, Inc., Clint, Tex. Verwendung einer zusammensetzung mit therapeutischer wirksamkeit
US4464357A (en) * 1983-05-26 1984-08-07 T&R Chemicals, Inc. Treatment of epilepsy with bisulfite
US4532131A (en) * 1984-05-08 1985-07-30 T And R Chemicals, Inc. Therapeutic compositions

Also Published As

Publication number Publication date
EP0274404A1 (en) 1988-07-13
IL81166A (en) 1990-03-19
IL81166A0 (en) 1987-08-31
US5045316A (en) 1991-09-03
AU594851B2 (en) 1990-03-15
JPS63239227A (ja) 1988-10-05
AU8316587A (en) 1988-07-07

Similar Documents

Publication Publication Date Title
FR2623401B1 (ja)
GR2000074Y (ja)
GR3003956T3 (ja)
GR3004653T3 (ja)
GR3004280T3 (ja)
FR2675468B1 (ja)
GR3003857T3 (ja)
IN166557B (ja)
GR3004537T3 (ja)
IN169658B (ja)
GR3004722T3 (ja)
GR3005574T3 (ja)
FR2623743B1 (ja)
GR3004717T3 (ja)
FR2611840B1 (ja)
DE3870774D1 (ja)
GR3003751T3 (ja)
FR2635847B1 (ja)
CH680485GA3 (ja)
DE3776321D1 (ja)
FR2623765B1 (ja)
AU6265086A (ja)
IN165685B (ja)
AU6741387A (ja)
IN170449B (ja)